Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AusBiotech Chief Executive Anna Lavelle On Biotech’s Role In Asia Pacific: An Interview with PharmAsia News (Part 2 of 2)

This article was originally published in PharmAsia News

Executive Summary

PERTH, Australia - AusBiotech is Australia's Biotechnology Industry Organization, which represents over 2,400 members, covering the human health, agricultural, medical device, bioinformatics, environmental and industrial sectors in biotechnology. AusBiotech has representation in each Australian state providing a national network to support members and promote the commercialization of Australian bioscience in the national and international marketplaces. Ausbiotech Chief Executive Dr. Anna Lavelle recently talked with PharmAsia News' Australian bureau about the role of the Australian biotech sector in Australia and globally.

You may also be interested in...



AusBiotech Chief Executive Anna Lavelle On Biotech’s Role In Asia Pacific: An Interview with PharmAsia News (Part 1 of 2)

PERTH, Australia - AusBiotech is Australia's Biotechnology Industry Organization, which represents over 2,400 members, covering the human health, agricultural, medical device, bioinformatics, environmental and industrial sectors in biotechnology. AusBiotech has representation in each Australian state providing a national network to support members and promote the commercialization of Australian bioscience in the national and international marketplaces. AusBiotech Chief Executive Dr. Anna Lavelle recently talked with PharmAsia News' Australian bureau about the role of the Australian biotech sector in Australia and globally.

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068695

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel